← All companies
VYGR
Voyager Therapeutics, Inc.
$3.00
-0.13 -4.15%
Key statistics
from XBRL data in SEC filingsMarket cap
$181M
Revenue (TTM)
$36.5M
Net income (TTM)
-$117M
EPS (TTM)
$-1.98
P/E ratio
—
Dividend yield
—
Free cash flow
-$135M
Cash
$43.3M
Total assets
$219M
Gross margin
—
52-week range
$2.88 – $5.55
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jul 13, 2026
8-K
Amended charter or bylaws; Shareholder vote results
Jun 10, 2026
8-K
Other events
Jun 1, 2026
8-K
Results of operations (earnings release)
May 7, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Director or officer change
Apr 21, 2026
8-K
Results of operations (earnings release)
Mar 9, 2026
10-K
Fiscal year ended 2025-12-31
Mar 9, 2026
8-K
Director or officer change; Other events
Feb 12, 2026
8-K
Regulation FD disclosure
Jan 8, 2026
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release)
Nov 10, 2025
8-K
Regulation FD disclosure
Sep 2, 2025
10-Q
Quarter ended 2025-06-30
Aug 6, 2025
8-K
Results of operations (earnings release)
Aug 6, 2025
8-K
Director or officer change; Shareholder vote results
Jun 5, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release)
May 6, 2025
10-K
Fiscal year ended 2024-12-31
Mar 11, 2025
8-K
Results of operations (earnings release)
Mar 11, 2025
8-K
Other events
Feb 11, 2025
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Results of operations (earnings release)
Nov 12, 2024
8-K
Entered a material agreement
Sep 5, 2024
10-Q
Quarter ended 2024-06-30
Aug 6, 2024
8-K
Results of operations (earnings release)
Aug 6, 2024
8-K
Director or officer change
Jun 13, 2024
8-K
Shareholder vote results
Jun 6, 2024
8-K
Other events
May 16, 2024
10-Q
Quarter ended 2024-03-31
May 13, 2024
8-K
Results of operations (earnings release)
May 13, 2024
8-K
Director or officer change
Apr 2, 2024
8-K
Other events
Mar 13, 2024
10-K
Fiscal year ended 2023-12-31
Feb 28, 2024
8-K
Results of operations (earnings release)
Feb 28, 2024
8-K
Entered a material agreement; Other events
Jan 8, 2024
8-K
Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Other events
Jan 2, 2024
8-K
Other events
Dec 6, 2023
10-Q
Quarter ended 2023-09-30
Nov 6, 2023
8-K
Results of operations (earnings release)
Nov 6, 2023